Effect of actinomycin D on estrogen-induced changes in enzymes and nucleic acids of R3230AC mammary tumors, uteri, and mammary glands.
D000818:Animals; D004247:DNA / Q000096:biosynthesis*; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D003609:Dactinomycin / Q000494:pharmacology*; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D005956:Glucose-6-Phosphate Isomerase / Q000378:metabolism*; D066298:In Vitro Techniques; D008321:Mammary Glands, Animal / Q000201:enzymology* / Q000378:metabolism*; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism*; D010088:Oxidoreductases / Q000378:metabolism*; D010733:Phosphoglucomutase / Q000378:metabolism*; D010770:Phosphotransferases / Q000378:metabolism*; D011691:Puromycin / Q000494:pharmacology; D012313:RNA / Q000096:biosynthesis*; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D051381:Rats; D014599:Uterus / Q000201:enzymology* / Q000378:metabolism*
D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D003609:Dactinomycin; D011691:Puromycin; D004958:Estradiol; D012313:RNA; D004247:DNA; D010088:Oxidoreductases; D010770:Phosphotransferases; D005956:Glucose-6-Phosphate Isomerase; D010733:Phosphoglucomutase